BioAge Labs Balance Sheet Health
Financial Health criteria checks 5/6
BioAge Labs has a total shareholder equity of $145.7M and total debt of $11.4M, which brings its debt-to-equity ratio to 7.8%. Its total assets and total liabilities are $164.4M and $18.7M respectively.
Key information
7.8%
Debt to equity ratio
US$11.37m
Debt
| Interest coverage ratio | n/a |
| Cash | US$159.09m |
| Equity | US$145.70m |
| Total liabilities | US$18.70m |
| Total assets | US$164.40m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: Y7G's short term assets ($163.7M) exceed its short term liabilities ($13.0M).
Long Term Liabilities: Y7G's short term assets ($163.7M) exceed its long term liabilities ($5.7M).
Debt to Equity History and Analysis
Debt Level: Y7G has more cash than its total debt.
Reducing Debt: Insufficient data to determine if Y7G's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Y7G has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Y7G has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 16.4% each year.